SCHEMBL463058

SCHEMBL463058

Cc1nc2cc(-c3cccc(Cl)c3)nn2c(C2CCCCC2)c1C(=O)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.44
KMT2A Q03164 1/20 0.44
ABCB1 P08183 1/20 0.44
HPGD P15428 7/20 0.43
KDM4E B2RXH2 6/20 0.43
ALDH1A1 P00352 6/20 0.43
HSD17B10 Q99714 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
LMNA P02545 3/20 0.43
MAPK1 P28482 3/20 0.43
HTT P42858 3/20 0.43
TSHR P16473 2/20 0.43
TP53 P04637 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
USP2 O75604 1/20 0.43
DPP4 P27487 2/20 0.42
DPP8 Q6V1X1 2/20 0.42
DPP9 Q86TI2 2/20 0.42
MAPT P10636 3/20 0.41
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL461427 0.90 RXFP1 (0.43) NPSR1KMT2AABCB1HPGDKDM4E
SCHEMBL12079175 0.83 ABCB1 (0.44) NPSR1KMT2AABCB1HPGDKDM4E
SCHEMBL463059 0.81 DPP4 (0.52) NPSR1KMT2AABCB1HPGDKDM4E
SCHEMBL461832 0.80 NR1I2 (0.49) NPSR1KMT2AABCB1HPGDKDM4E
SCHEMBL462611 0.80 NR1I2 (0.49) NPSR1KMT2AABCB1HPGDKDM4E
SCHEMBL461151 0.79 ABCB1 (0.43) NPSR1KMT2AABCB1HPGDKDM4E
SCHEMBL461150 0.79 ABCB1 (0.43) NPSR1KMT2AABCB1HPGDKDM4E
SCHEMBL462882 0.77 NR1I2 (0.42) NPSR1KMT2AABCB1HPGDKDM4E
SCHEMBL461015 0.77 NR1I2 (0.42) NPSR1KMT2AABCB1HPGDKDM4E
SCHEMBL462683 0.77 KDM4E (0.49) NPSR1KMT2AHPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2614064-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Bristol-Myers Squibb Company (US) 2013-07-17 EP disclosed
WO-2012033735-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed